Author

T. Tomita

Observed name: Tetsuya Tomita

Institutions: Morinomiya University of Medical Sciences, The University of Osaka

Observed institutions: Morinomiya University of Medical Sciences, The University of Osaka

OpenAlex ID: A5026889262

Op0019 Bimekizumab in Patients With Active Ankylosing Spondylitis: 24-week Efficacy & Safety From Be Mobile 2, a Phase 3, Multicentre, Randomised, Placebo-controlled Study

2022 · D. Van der Heijde, X. Baraliakos, et al. · Annals of the Rheumatic Diseases · 5

Pos0215 Long-term Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: 5-year Results From a Phase 2b Study and Its Open-label Extension

2024 · A. Deodhar, V. Navarro-Compán, et al. · Annals of the Rheumatic Diseases · 2

Pos0788 Bimekizumab Demonstrated Sustained Efficacy and Safety Across the Full Spectrum of Axial Spondyloarthritis: 3-year Results From Two Phase 3 Studies and Their Open-label Extension

2025 · X. Baraliakos, A. Deodhar, et al. · Annals of the Rheumatic Diseases · 1

Correction: The effect of weight-bearing status on kinematics and cruciate ligament force in normal knees

2026 · Kenichi Kono, Ryo Murakami, et al. · Scientific Reports

Works count: 4

Citation count: 8

H-index: 2

I10-index: